The silencing of ZFAS1 can impede the proliferation, EMT and metastatic dissemination of GC cells, along with the attenuated chemoresistance of GC cells toward chemotherapeutics such as cis-platinum or paclitaxel [196]. This evidence concerns the gene ZFAS1 and gastric cancer.